1: Hudzik TJ, Patel M, Brown A. β2 -Adrenoceptor agonist activity of higenamine. Drug Test Anal. 2020 Dec 26. doi: 10.1002/dta.2992. Epub ahead of print. PMID: 33369180.
2: Zhang N, Lian Z, Peng X, Li Z, Zhu H. Applications of Higenamine in pharmacology and medicine. J Ethnopharmacol. 2017 Jan 20;196:242-252. doi: 10.1016/j.jep.2016.12.033. Epub 2016 Dec 19. PMID: 28007527.
3: Zhang Y, Zhang J, Wu C, Guo S, Su J, Zhao W, Xing H. Higenamine protects neuronal cells from oxygen-glucose deprivation/reoxygenation-induced injury. J Cell Biochem. 2019 Mar;120(3):3757-3764. doi: 10.1002/jcb.27656. Epub 2018 Sep 30. PMID: 30270549.
4: Wang X, Li X, Jingfen W, Fei D, Mei P. Higenamine alleviates cerebral ischemia-reperfusion injury in rats. Front Biosci (Landmark Ed). 2019 Mar 1;24:859-869. PMID: 30844718.
5: Cohen PA, Travis JC, Keizers PHJ, Boyer FE, Venhuis BJ. The stimulant higenamine in weight loss and sports supplements. Clin Toxicol (Phila). 2019 Feb;57(2):125-130. doi: 10.1080/15563650.2018.1497171. Epub 2018 Sep 6. PMID: 30188222.
6: Bai X, Ding W, Yang S, Guo X. Higenamine inhibits IL-1β-induced inflammation in human nucleus pulposus cells. Biosci Rep. 2019 Jun 28;39(6):BSR20190857. doi: 10.1042/BSR20190857. PMID: 31213577; PMCID: PMC6597855.
7: Nuntawong P, Tanaka H, Sakamoto S, Morimoto S. ELISA for the Detection of the Prohibited Doping Agent Higenamine. Planta Med. 2020 Jul;86(11):760-766. doi: 10.1055/a-1181-2084. Epub 2020 Jun 8. PMID: 32512615.
8: Guan J, Lin H, Xie M, Huang M, Zhang D, Ma S, Bian W, Zhan Q, Zhao G. Higenamine exerts an antispasmodic effect on cold-induced vasoconstriction by regulating the PI3K/Akt, ROS/α2C-AR and PTK9 pathways independently of the AMPK/eNOS/NO axis. Exp Ther Med. 2019 Aug;18(2):1299-1308. doi: 10.3892/etm.2019.7656. Epub 2019 Jun 10. PMID: 31316621; PMCID: PMC6601373.
9: Deng T, Wei Z, Gael A, Deng X, Liu Y, Lai J, Hang L, Yan Q, Fu Q, Li Z. Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway. J Cardiovasc Pharmacol. 2020 Jun;75(6):535-544. doi: 10.1097/FJC.0000000000000822. PMID: 32168151.
10: Yan K, Wang X, Wang Z, Wang Y, Luan Z, Gao X, Wang R. The risk of higenamine adverse analytical findings following oral administration of plumula nelumbinis capsules. Drug Test Anal. 2019 Nov;11(11-12):1731-1736. doi: 10.1002/dta.2701. Epub 2019 Nov 27. PMID: 31680485.